Cargando…
New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
Cluster of differentiation 27 (CD27) is a member of the tumour necrosis factor receptor superfamily and plays a key role in T-cell activation by providing a costimulatory signal. Bound to its natural ligand CD70, CD27 signalling enhances T-cell proliferation and differentiation to effector and memor...
Autores principales: | Starzer, Angelika M., Berghoff, Anna S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082637/ https://www.ncbi.nlm.nih.gov/pubmed/32152062 http://dx.doi.org/10.1136/esmoopen-2019-000629 |
Ejemplares similares
-
Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
por: Starzer, Angelika M., et al.
Publicado: (2022) -
New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)
por: Piechutta, Manuel, et al.
Publicado: (2019) -
Nachwuchsförderung durch die European Society for Medical Oncology (ESMO): Erfahrungen aus dem ESMO Young Oncologist Committee (YOC)
por: Oing, Christoph, et al.
Publicado: (2020) -
Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
por: Fendl, B., et al.
Publicado: (2023) -
CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development
por: Hashimoto, Kenji
Publicado: (2021)